Lactobacillus gallinarium releases indole-3-carboxylic acid (ICA), which competes with kynurenine to bind AhR and inhibit tumor-infiltrating Tregs, resulting in increased IFN-γ+ CD8+ T cells in tumors and increased response to anti–PD-1 treatment (9). This evidence concerns the gene CD8A and neoplasm.